Dicoumarol alters cellular redox state and inhibits Nuclear Factor kappa B to enhance arsenic trioxide-induced apoptosis

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 3, 2004, Pages 235-242

  Jing, Ya Wu ^a   Yi, Jing ^a   Chen, Yu Ying ^a   Hu, Qing Shen ^a   Shi, Gui Ying ^a   Li, Hue ^a   Tang, Xue Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Arsenic trioxide; Dicoumarol; NF B; Reduction oxidation state

Indexed keywords

ARSENIC TRIOXIDE; DICOUMAROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; OXIDATION REDUCTION REACTION; WESTERN BLOTTING;

EID: 2442466852     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.3.235     Document Type: Article

References (26)

1. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem, 2001, 11(4): 173-186
2. Jing YW, Yi J, Gao F, Tang XM. Reactive oxygen species: from toxic molecules to messengers-Reactive oxygen species signaling in cell proliferation, differentiation and apoptosis. Chin J Cell Biol, 2003, 25(4): 197-202
3. Yi J, Gao F, Shi G, Li H, Wang Z, Shi X, Tang X. The inherent cellular level of reactive oxygen species: One of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis, 2002, 7(3): 209-215
4. Bode AM, Dong Z. The paradox of arsenic: Molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol, 2002, 42(1): 5-24
5. Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans, 2001, 29(Pt 2): 345-350
6. Gao F, Yi J, Shi GY, Li H, Jin HF, Shi XG, Tang XM. The susceptibility of leukemia cells to arsenic trioxide-induced apoptosis is determined by cellular reactive oxygen species level. Acta Biochim Biophys Sin, 2001, 33 (5): 585-589
7. Yi J, Yang J, He R, Gao F, Sang H, Tang X Ye RD. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res, 2004, 64:(1): 108-116
8. Hosoda S, Nakamura W, Hayashi K. Properties and reaction mechanism of DT diaphorase from rat liver. J Biol Chem, 1974, 249(20): 6416-6423
9. Jiang G, Nepomuceno L, Hopkins K, Sladek FM. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol, 1995, 15(9): 5131-5143
10. Cross JV, Deak JC, Rich EA, Qian Y, Lewis M, Parrott LA, Mochida K et al. Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem, 1999, 274(44): 31150-31154
11. Kishi T, Takahashi T, Mizobuchi S, Mori K, Okamoto T. Effect of dicumarol, a NAD(P)H: Quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes. Free Radic Res, 2002, 36(4): 413-419
12. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA, 2002, 99(5): 3099-3104
13. Droge W. Free radicals in the physiological control of cell function. Physiol Rev, 2002, 82(1): 47-95
14. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol, 2000, 279(6): L1005-L1028
15. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol, 2002, 3(3): 221-227
16. Korn SH, EWouters F., Vos N, Janssen-Heininger YM. Cytokine-induced activation of nuclear factor-κB is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J Biol Chem, 2001, 276: 35693-35700
17. Nakao S, Ogtata Y, Shimizu E, Yamazaki M, Furuyama S, Sugiya H. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NF-κB in human gingival fibroblasts. Mol Cell Biochem, 2002, 238 (1-2): 11-18
18. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor NF-κB in human neutrophils. J Biol Chem, 2004, 279(4): 2657-2665
19. Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J, 2002, 16(14): 1931-1933
20. Mercurio F, Manning AM. NF-κB as a primary regulator of the stress response. Oncogene, 1999, 18(45): 6163-6171
21. Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal, 2002, 14(11): 879-897
22. Kitazawa M, Nakano T, Chuujou H, Shiojiri E, Iwasaki K, Sakamoto K. Intracellular redox regulation by a cysteine derivative suppresses UV-induced NF-κB activation. FEBS Lett, 2002, 526(1-3): 106-110
23. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M, Aizawa S et al. Spatial redox regulation of a critical cysteine residue of NF-κB in vivo. J Biol Chem, 2002, 277(46): 44548-44556
24. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today, 1998, 19(2): 80-88
25. Chiou SK, Jones MK, Tamawski AS. Survivin- an anti-apoptosis protein: Its biological roles and implications for cancer and beyond. Med Sci Monit, 2003, 9(4): 125-129
26. Yang J, Chen YY, Wang XJ, Shi GY, Hu QS, Kang XL, Lu Y et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radic. Biol. Med., submitted